Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication. - Wikidata - wikimedia - TriplyDB

Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication.

Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication.

http://www.wikidata.org/entity/Q37670270

about

Fontan's circulation with dextrocardia, recent pulmonary embolism, and inferior vena cava filter: Anesthetic challenges for urgent hysterectomy Implications and limitations of the PREPIC2 study-the interventionist's perspective.

P2860

Q36987948-C977B113-3F36-47D8-B8C3-DA2D0FB60320 Q42094971-46A831DA-AC8B-4A34-82EA-D3780C4BC5D3

P2860

Benefit vs. Risk of a Permanent Inferior Vena Cava Filter in Pulmonary Embolism with Anticoagulation Contraindication.

http://www.wikidata.org/entity/Q37670270

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@en

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@nl

type

label

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@en

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@nl

prefLabel

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@en

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@nl

P1433

Q37670270-419C05E4-0383-4C46-904D-AE16D184B906

P1476

Q37670270-98F0C422-9B83-480D-ADFF-92F4E22AE69D

P2093

Q37670270-1554BD45-3F9C-46DD-9381-36FF783BE33D

Q37670270-3FC8EC7B-88F7-45EC-9D81-343C2DAE380D

Q37670270-AA2331B4-8BC2-4DB0-86B0-9BD688CB00C4

P2860

Q37670270-10B8598F-C4C2-4EA7-AEC2-6B7218104B08

Q37670270-5829B698-AE04-4D0D-89E5-2D1A6100AF5B

Q37670270-7E9DA89C-4EFE-48A7-8C1A-8588C504AEBC

Q37670270-8ADFA1E8-E5FF-4364-B28B-2E5A26AE90E3

Q37670270-8B63CC27-90C9-4E06-A6FA-BE552395325A

Q37670270-8C682EEE-E95B-4030-BAB6-DE1CCDB7A69E

Q37670270-8F5F7B17-5A2C-407E-99A6-92F8B5F97145

Q37670270-96169250-4453-41CD-8674-08B05348D65C

Q37670270-9CE2E2B0-2403-4AD2-862E-652E9F72E7A1

Q37670270-C0BB2FA0-D429-4D8A-8850-077329D47A9B

P304

Q37670270-8E344F7E-3C81-499B-AD0B-7CA08F5BD2FA

P31

Q37670270-91AF287D-1FE2-4E04-97FD-5FDAC49C5C1E

Q37670270-91c4891b-3634-49cf-b3af-925fa58b0727

P433

Q37670270-CEEC9AC3-DBB1-4714-B241-2C83B586E9F4

P478

Q37670270-56024AE4-FC2F-4C36-9395-892BD2D600DD

P577

Q37670270-F3C862A8-6B5A-4B1A-AB55-C4F9A75C3BCE

P698

Q37670270-DBB4527B-CD44-434E-AB9D-451FAFD5A0C6

P921

Q37670270-E12AC908-81E7-4A2F-840C-DF8D4BF40672

P932

Q37670270-0AA96587-9299-48FA-8FA6-56DDD282E96B

P1433

P1476

Benefit vs. Risk of a Permanen ...... icoagulation Contraindication.

@en

P2093

Ionela-Simona Calin

http://www.w3.org/2001/XMLSchema#string

Lucia-Stefania Magda

http://www.w3.org/2001/XMLSchema#string

Mircea Cinteza

http://www.w3.org/2001/XMLSchema#string

P2860

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

Vena caval filters: a comprehensive review.

Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center.

A new intracaval filter permitting continued flow and resolution of emboli.

Natural history of venous thromboembolism.

Transvenous caval interruption with umbrella filter.

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis.

A population-based study of inferior vena cava filters in patients with acute venous thromboembolism

P304

355-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24790668

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3968472

http://www.w3.org/2001/XMLSchema#string